---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-092089"
form_type: "8-K"
ticker: "ATNM"
cik: "0001388320"
company_name: "Actinium Pharmaceuticals, Inc."
filed_at: "2023-12-01T23:59:59+00:00"
generated_at: "2026-06-07T19:16:39.626074+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Actinium shareholders re-elect Nicholson, Steinhart as Class I directors; Marcum LLP ratified as auditor

## Summary
- David Nicholson re-elected: 3,959,659 for, 3,275,844 withheld, 9,087,835 broker non-votes.
- Richard Steinhart re-elected: 5,630,379 for, 1,777,251 withheld, 9,087,835 broker non-votes.
- Marcum LLP ratified as independent auditor for FY2023: 15,842,146 for, 372,774 against, 280,545 abstain.
- No other matters voted on at the November 30, 2023 annual meeting.

## SEC filing metadata
- accession: 0001213900-23-092089
- form_type: 8-K
- ticker: ATNM
- cik: 0001388320
- company_name: Actinium Pharmaceuticals, Inc.
- filed_at: 2023-12-01T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1388320/000121390023092089/0001213900-23-092089-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1388320/000121390023092089/ea189365-8k_actinium.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-092089
- JSON: https://secwatch.observer/filing/0001213900-23-092089.json
- Plain text: https://secwatch.observer/filing/0001213900-23-092089.txt

## Key facts
- Shareholder Votes
  Actinium Pharmaceuticals, Inc. shareholders approved Election of David Nicholson and Richard I. Steinhart as Class I directors.
  - Proposal: director election
  - Outcome: passed
  source text: Director For Withhold Broker Non-Votes David Nicholson 3,959,659 3,275,844 9,087,835 Richard I. Steinhart 5,630,379 1,777,251 9,087,835
  evidence_url: https://www.sec.gov/Archives/edgar/data/1388320/000121390023092089/0001213900-23-092089-index.htm
- Shareholder Votes
  Actinium Pharmaceuticals, Inc. shareholders approved Ratification of appointment of Marcum LLP as independent registered public accounting firm for fiscal year ending December 31, 2023.
  - Proposal: auditor ratification
  - Outcome: passed
  source text: For Against Abstain Broker Non-Votes 15,842,146 372,774 280,545 N/A
  evidence_url: https://www.sec.gov/Archives/edgar/data/1388320/000121390023092089/0001213900-23-092089-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.